Consun Pharma repurchases 102,000 shares for HK$1.47 million; treasury stock rises to 152,000 shares

Bulletin Express05-21 19:25

Consun Pharmaceutical Group Limited (Consun Pharma) disclosed a share buyback completed on 21 May 2026, purchasing 102,000 ordinary shares on the Hong Kong Stock Exchange.

• Transaction details – Buy-back volume: 102,000 shares – Price range: HK$14.37–HK$14.47 per share – Volume-weighted average price: HK$14.44 per share – Aggregate consideration: HK$1.47 million

• Capital structure after the transaction (21 May 2026) – Issued shares (excluding treasury): 841.40 million – Treasury shares: 152,000 – Total issued shares (including treasury): 841.55 million

• Repurchase mandate utilisation – Authorised under mandate dated 22 May 2025: 85.13 million shares – Cumulative shares bought back under the mandate: 13.83 million shares, representing 16.25 % of the issued shares at the mandate date – Moratorium on new share issues or treasury-share sales: in force until 20 June 2026

All repurchased shares from this transaction are being retained as treasury shares; none have been cancelled. The company confirmed that the repurchase complied with Hong Kong listing rules and all applicable regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment